Neoleukin Therapeutics emerged from the University of Washington Institute for Protein Design in January of 2019. They are creating next generation immunotherapies using breakthrough de novo protein design technology.
Sutro Biopharma
3 followers
Active Motif
3 followers
Dyno Therapeutics
4 followers
Janux Therapeutics
1 follower
Eikon Therapeutics
4 followers
Gilead Sciences
188 followers
Regeneron
156 followers
Illumina
85 followers
Agilent Technologies
94 followers
Verily Life Sciences
48 followers
Alexion Pharmaceuticals
51 followers